Other Non-current Liabilities	6 Months Ended
Jun. 30, 2026
Payables and Accruals [Abstract]
Other Non-current Liabilities	Other Noncurrent Liabilities In March 2012, the Company entered into arrangements with certain former executive officers, whereby the Company is required to make payments to such former officers based on net revenues of voclosporin for a certain period of time. As of June 30, 2026 and December 31, 2025, the Company recorded other noncurrent liabilities of $0.9 million and $6.7 million, respectively. During the three months ended June 30, 2026, the Company made a one-time payment to fully settle all future obligations under one former officer’s arrangement.

Other Non-current Liabilities

6 Months Ended

Jun. 30, 2026

Other Noncurrent Liabilities

In March 2012, the Company entered into arrangements with certain former executive officers, whereby the Company is required to make payments to such former officers based on net revenues of voclosporin for a certain period of time. As of June 30, 2026 and December 31, 2025, the Company recorded other noncurrent liabilities of $0.9 million and $6.7 million, respectively. During the three months ended June 30, 2026, the Company made a one-time payment to fully settle all future obligations under one former officer’s arrangement.